SCHEMBL22111797

SCHEMBL22111797

O=C1CC(c2ccccc2)CC(O)/C1=C\NCCN1CCNCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP1LC3B Q9GZQ8 8/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ MAPT P10636 2/20 0.40
▸ CARM1 Q86X55 1/20 0.37
▸ PRMT6 Q96LA8 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ CYP2C19 P33261 1/20 0.36
▸ GAA P10253 2/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ KDM1A O60341 1/20 0.36
▸ CHRM2 P08172 1/20 0.36
▸ CHRM4 P08173 1/20 0.36
▸ CHRM5 P08912 1/20 0.36
▸ CHRM1 P11229 1/20 0.36
▸ CHRM3 P20309 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ SIGMAR1 Q99720 1/20 0.35
▸ HTR4 Q13639 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24379788 0.88 SLC18A3 (0.45) MAP1LC3BALDH1A1CARM1PRMT6CYP2C19
SCHEMBL21822002 0.82 MEN1 (0.48) MAP1LC3BALDH1A1MAPTCARM1PRMT6
SCHEMBL22111791 0.76 LMNA (0.39) ALDH1A1MAPTMEN1KMT2A
SCHEMBL21821944 0.72 MAP1LC3B (0.57) MAP1LC3BALDH1A1MAPTKDM4ECYP2C19
SCHEMBL22057831 0.72 MAP1LC3B (0.57) MAP1LC3BALDH1A1MAPTKDM4EGAA
SCHEMBL21821591 0.71 SLC18A3 (0.50) MAP1LC3BALDH1A1CARM1PRMT6CYP2C19
SCHEMBL21821806 0.70 CYP3A4 (0.54) MAP1LC3BALDH1A1KDM4ECYP2C19L3MBTL1
SCHEMBL26530728 0.70 MEN1 (0.49) MAP1LC3BCARM1PRMT6CYP2C19MEN1
SCHEMBL22056804 0.69 MAP1LC3B (0.59) MAP1LC3BALDH1A1MAPTGAAL3MBTL1
SCHEMBL22056945 0.69 CYP2C19 (0.58) MAP1LC3BALDH1A1MAPTCARM1PRMT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11319303-B2 Compound used as autophagy regulator, and preparation method therefor and uses thereof Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2022-05-03 — — US disclosed
US-20200190066-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2020-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11319303-B2 Compound used as autophagy regulator, and preparation method therefor and uses thereof ATG7, SQSTM1, BECN1 MAP1LC3B 15/4885ALDH1A1 4264/4885MAPT 763/4885
US-20200190066-A1 COMPOUND USED AS AUTOPHAGY REGULATOR, AND PREPARATION METHOD THEREFOR AND USES THEREOF ATG7, SQSTM1, BECN1 MAP1LC3B 15/4885ALDH1A1 4264/4885MAPT 763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback